IBD-what role do Proteobacteria play?

Indrani Mukhopadhya, Richard Hansen, Emad M El-Omar, Georgina L Hold

Research output: Contribution to journalLiterature review

226 Citations (Scopus)

Abstract

The gastrointestinal microbiota has come to the fore in the search for the causes of IBD. This shift has largely been driven by the finding of genetic polymorphisms involved in gastrointestinal innate immunity (particularly polymorphisms in NOD2 and genes involved in autophagy) and alterations in the composition of the microbiota that might result in inflammation (so-called dysbiosis). Microbial diversity studies have continually demonstrated an expansion of the Proteobacteria phylum in patients with IBD. Individual Proteobacteria, in particular (adherent-invasive) Escherichia coli, Campylobacter concisus and enterohepatic Helicobacter, have all been associated with the pathogenesis of IBD. In this Review, we comprehensively describe the various associations of Proteobacteria and IBD. We also examine the importance of pattern recognition in the extracellular innate immune response of the host with particular reference to Proteobacteria, and postulate that Proteobacteria with adherent and invasive properties might exploit host defenses, drive proinflammatory change, alter the intestinal microbiota in favor of dysbiosis and ultimately lead to the development of IBD.
Original languageEnglish
Pages (from-to)219-230
Number of pages12
JournalNature Reviews Gastroenterology & Hepatology
Volume9
DOIs
Publication statusPublished - Apr 2012

Fingerprint

Proteobacteria
Dysbiosis
Innate Immunity
Helicobacter
Campylobacter
Microbiota
Autophagy
Genetic Polymorphisms
Escherichia coli
Inflammation
Genes

Cite this

IBD-what role do Proteobacteria play? / Mukhopadhya, Indrani; Hansen, Richard; El-Omar, Emad M; Hold, Georgina L.

In: Nature Reviews Gastroenterology & Hepatology, Vol. 9, 04.2012, p. 219-230.

Research output: Contribution to journalLiterature review

@article{dcb084f892124d9fb2ce69f0cfdf774d,
title = "IBD-what role do Proteobacteria play?",
abstract = "The gastrointestinal microbiota has come to the fore in the search for the causes of IBD. This shift has largely been driven by the finding of genetic polymorphisms involved in gastrointestinal innate immunity (particularly polymorphisms in NOD2 and genes involved in autophagy) and alterations in the composition of the microbiota that might result in inflammation (so-called dysbiosis). Microbial diversity studies have continually demonstrated an expansion of the Proteobacteria phylum in patients with IBD. Individual Proteobacteria, in particular (adherent-invasive) Escherichia coli, Campylobacter concisus and enterohepatic Helicobacter, have all been associated with the pathogenesis of IBD. In this Review, we comprehensively describe the various associations of Proteobacteria and IBD. We also examine the importance of pattern recognition in the extracellular innate immune response of the host with particular reference to Proteobacteria, and postulate that Proteobacteria with adherent and invasive properties might exploit host defenses, drive proinflammatory change, alter the intestinal microbiota in favor of dysbiosis and ultimately lead to the development of IBD.",
author = "Indrani Mukhopadhya and Richard Hansen and El-Omar, {Emad M} and Hold, {Georgina L}",
year = "2012",
month = "4",
doi = "10.1038/nrgastro.2012.14",
language = "English",
volume = "9",
pages = "219--230",
journal = "Nature Reviews Gastroenterology & Hepatology",
issn = "1759-5045",
publisher = "Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.",

}

TY - JOUR

T1 - IBD-what role do Proteobacteria play?

AU - Mukhopadhya, Indrani

AU - Hansen, Richard

AU - El-Omar, Emad M

AU - Hold, Georgina L

PY - 2012/4

Y1 - 2012/4

N2 - The gastrointestinal microbiota has come to the fore in the search for the causes of IBD. This shift has largely been driven by the finding of genetic polymorphisms involved in gastrointestinal innate immunity (particularly polymorphisms in NOD2 and genes involved in autophagy) and alterations in the composition of the microbiota that might result in inflammation (so-called dysbiosis). Microbial diversity studies have continually demonstrated an expansion of the Proteobacteria phylum in patients with IBD. Individual Proteobacteria, in particular (adherent-invasive) Escherichia coli, Campylobacter concisus and enterohepatic Helicobacter, have all been associated with the pathogenesis of IBD. In this Review, we comprehensively describe the various associations of Proteobacteria and IBD. We also examine the importance of pattern recognition in the extracellular innate immune response of the host with particular reference to Proteobacteria, and postulate that Proteobacteria with adherent and invasive properties might exploit host defenses, drive proinflammatory change, alter the intestinal microbiota in favor of dysbiosis and ultimately lead to the development of IBD.

AB - The gastrointestinal microbiota has come to the fore in the search for the causes of IBD. This shift has largely been driven by the finding of genetic polymorphisms involved in gastrointestinal innate immunity (particularly polymorphisms in NOD2 and genes involved in autophagy) and alterations in the composition of the microbiota that might result in inflammation (so-called dysbiosis). Microbial diversity studies have continually demonstrated an expansion of the Proteobacteria phylum in patients with IBD. Individual Proteobacteria, in particular (adherent-invasive) Escherichia coli, Campylobacter concisus and enterohepatic Helicobacter, have all been associated with the pathogenesis of IBD. In this Review, we comprehensively describe the various associations of Proteobacteria and IBD. We also examine the importance of pattern recognition in the extracellular innate immune response of the host with particular reference to Proteobacteria, and postulate that Proteobacteria with adherent and invasive properties might exploit host defenses, drive proinflammatory change, alter the intestinal microbiota in favor of dysbiosis and ultimately lead to the development of IBD.

U2 - 10.1038/nrgastro.2012.14

DO - 10.1038/nrgastro.2012.14

M3 - Literature review

VL - 9

SP - 219

EP - 230

JO - Nature Reviews Gastroenterology & Hepatology

JF - Nature Reviews Gastroenterology & Hepatology

SN - 1759-5045

ER -